Living with immune suppression in 2021

Post date: 2021-11-28 14:16:26
Views: 192
What do people do to have the best, most active life while on immune suppressants in 2021? (More details inside, if curious, but this is the tl;dr)

I have been on immune suppressants since June for psoriatic arthritis. Having a suppressed immune system is scary right now and I got sick this past semester a lot, now that we are more or less back to being in person where I work (a lot > 6 weeks of the semester).

I have a therapist and I have talked to my doctor, who was kind and had some good suggestions but basically shrugged and said "this may be your new normal."

If you or a friend or family member are immune suppressed, what are you doing to get through this time when it seems like everyone who isn't us can go back to "normal"? What helps you get sick less often?

I am ok emotionally and working with an excellent therapist and have a very good medical team. I also have a pretty supportive workplace but they don't really know how to help. I would like to know what others in my position are doing that might help.

Thanks in advance.
Number of Comments
Please click Here to read the full story.
 
Other Top and Latest Questions:
Waiting until January to make this move could trim up to $2,000 off your taxable income—about 90% of filers could benefit
Mercedes-Benz agrees to $149.6 million settlement with U.S. states over excess diesel emissions
Starbucks turnaround will take time. This options strategy works if shares remain range-bound
Free streaming service Tubi is rivaling major players for viewership. Here's how it's winning
It's too late for some last-minute tax moves — but these can be tackled with days to go in 2025
Arkansas ticket scoops $1.8 billion in Christmas Powerball jackpot
This convenience store chain is in a long-term upward trend with no signs of slowing, charts show
DOJ says more than 1 million potential Epstein files newly uncovered
Epstein files: DOJ restores image showing Trump after backlash
Disney's 'Avatar: Fire and Ash' disappoints with weak $88 million domestic opening